MENU
ANVS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Annovis Bio (ANVS) Earnings Date & Reports
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States... Show more
A.I. Advisor
published Earnings
ANVS is expected to report earnings to fall 34.13% to -41 cents per share on August 18
Q2'26
Est.
$-0.41
Q1'26
Missed
by $0.23
Q4'25
Missed
by $0.05
Q3'25
Missed
by $0.06
Q2'25
Beat
by $0.08
The last earnings report on May 15 showed earnings per share of -62 cents, missing the estimate of -40 cents. With 266.00K shares outstanding, the current market capitalization sits at 77.43M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders
Industry Biotechnology
Profile
Details
Industry
N/A
Address
101 Lindenwood Drive
Phone
+1 484 875-3192
Employees
6
Web
https://www.annovisbio.com